Theriva Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 233.3%.

Top 25 shareholders own 37.34% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.9%	Anson Group	225,000	€393.3k	0%	0.06%
9.9%	Armistice Capital LLC	225,000	€393.3k	0%	0.01%
7.92%	Heights Capital Management, Inc.	180,000	€314.6k	0%	0.14%
6.16%	Intracoastal Capital LLC	140,000	€244.7k	0%	no data
1.05%	MSD Partners, L.P.	23,936	€41.8k	0%	0.02%
0.45%	William Blair Investment Management, LLC	10,153	€17.7k	2,400%	no data
0.44%	Steven Shallcross	10,000	€17.5k	0%	no data
0.34%	The Vanguard Group, Inc.	7,779	€13.6k	-13.7%	no data
0.33%	BlackRock, Inc.	7,567	€13.2k	0%	no data
0.25%	Geode Capital Management, LLC	5,646	€9.9k	0%	no data
0.18%	Renaissance Technologies LLC	4,148	€7.2k	51.4%	no data
0.14%	Frank Tufaro	3,225	€5.6k	-0.03%	no data
0.11%	Two Sigma Securities, LLC, Asset Management Arm	2,440	€4.3k	187%	no data
0.086%	State Street Global Advisors, Inc.	1,947	€3.4k	0%	no data
0.047%	Northern Trust Global Investments	1,059	€1.9k	-0.38%	no data
0.019%	Advisor Group Holdings, Inc., Asset Management Arm	440	€769.0	0%	no data
0.0011%	Jeffrey Kraws	26	€45.3	0%	no data
0.00088%	Strategic Advisers LLC	20	€35.0	1,900%	no data
0.00062%	Iron Horse Wealth Management, LLC	14	€24.6	0%	no data
0.00048%	IFP Advisors, LLC	11	€19.1	0%	no data
0.00022%	Bank of America Corporation, Asset Management Arm	5	€8.7	400%	no data
0.00022%	Tower Research Capital Europe Limited	5	€8.7	0%	no data
0.00018%	Wells Fargo & Company, Securities and Brokerage Investments	4	€7.1	0%	no data
0.00018%	Planning Capital Management Corp.	4	€7.1	0%	no data
0.00004%	City National Rochdale, LLC	1	€1.6	0%	no data